Neovasc Inc. is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ for the treatment of refractory angina, the Tiara™ technology in development for the transcatheter treatment of mitral valve disease and a line of advanced biological tissue products that are used as key components in a variety of third-party medical products, such as vascular surgical patches and transcatheter heart valves.
Type
Public
HQ
Richmond, CA
Founded
2008
Employees
205 (est)+39%

Key People at Neovasc

Brian McPherson

Brian McPherson

COO
Alexei Marko

Alexei Marko

CEO & Director
Christopher Clark

Christopher Clark

CFO

Neovasc Locations

Richmond, CA

Neovasc Metrics

Neovasc Summary

Founding Date

2008

Market capitalization

$57.5 M

Closing share price

$0.51

Neovasc Market Value History

Neovasc Company Life

You may also be interested in